doi:10.3969/j.issn.1674-490X.2022.06.002

Abstract

Abstract: More and more evidences indicate that hypertension and end-organ damage of hypertension can be mediated not only by hemodynamic injury, but also by inflammation. Inflammation plays an important role in the pathophysiology of hypertension and mediates various complications by activating the immune response in the body. Complement, as a potential regulator of hypertension and the intersection of innate immunity and adaptive immunity, affects the occurrence and development of hypertension through both innate immunity and adaptive immunity. In this paper, we will review the interaction between complement and T lymphocytes in acquired immune cells during the occurrence and development of hypertension, in order to better understand the relationship between complement and hypertension, and provide new ideas for disease diagnosis and treatment.

Key words: hypertension, complement, T lymphocytes, adaptive immunity

CLC Number:

References

[1] WENZEL U O, BODE M, KÖHL J, et al. A pathogenic role of complement in arterial hypertension and hypertensive end organ damage[J]. Am J Physiol Heart Circ Physiol, 2017, 312(3): H349-H354. DOI: 10.1152/ajpheart.00759.2016.
[2] WENZEL U O, CLAUDIA K, MARLIES B. The role of complement in arterial hypertension and hypertensive end organ damage[J]. Br J Pharmacol, 2021, 178(14): 2849-2862. DOI: 10.1111/bph.15171.
[3] WENZEL U O, EHMKE H, BODE M. Immune mechanisms in arterial hypertension. Recent advances[J]. Cell Tissue Res, 2021, 385(2): 393-404. DOI: 10.1007/s00441-020-03409-0.
[4] GUZIK T J, HOCH N E, BROWN K A, et al. Role of the T cell in the genesis of angiotensin Ⅱ induced hypertension and vascular dysfunction[J]. J Exp Med, 2007, 204(10): 2449-2460. DOI: 10.1084/jem.20070657.
[5] YOUN J C, YU H T, LIM B J, et al. Immunosenescent CD8⁺ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension[J]. Hypertension, 2013, 62(1): 126-133. DOI: 10.1161/HYPERTENSIONAHA.113.00689.
[6] STRAINIC M G, LIU J B, HUANG D P, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4⁺ T cells[J]. Immunity, 2008, 28(3): 425-435. DOI: 10.1016/j.immuni.2008.02.001.
[7] KOLEV M, LE FRIEC G, KEMPER C. The role of complement in CD4⁺ T cell homeostasis and effector functions[J]. Semin Immunol, 2013, 25(1): 12-19. DOI: 10.1016/j.smim.2013.04.012.
[8] TLILI B, KASAL D A, LI M W, et al. T regulatory lymphocytes prevent angiotensin Ⅱ-induced hypertension and vascular injury[J]. Hypertens Dallas Tex 1979, 2011, 57(3): 469-76. DOI: 10.1161/HYPERTENSIONAHA.110.162941.
[9] COOPER M A, FEHNIGER T A, CALIGIURI M A. The biology of human natural killer-cell subsets[J]. Trends Immunol, 2001, 22(11): 633-640. DOI: 10.1016/s1471-4906(01)02060-9.
[10] SHAO J, NANGAKU M, MIYATA T, et al. Imbalance of T-cell subsets in angiotensin Ⅱ-infused hypertensive rats with kidney injury[J]. Hypertension, 2003, 42(1): 31-38. DOI: 10.1161/01.HYP.0000075082.06183.4E.
[11] KAMAT N V, THABET S R, XIAO L, et al. Renal transporter activation during angiotensin-Ⅱ hypertension is blunted in interferon-γ^-/- and interleukin-17A^-/- mice[J]. Hypertension, 2015, 65(3): 569-576. DOI: 10.1161/HYPERTENSIONAHA.114.04975.
[12] ZHANG J D, PATEL M B, GRIFFITHS R, et al. Tumor necrosis factor-α produced in the kidney contributes to angiotensin Ⅱ-dependent hypertension[J]. Hypertension, 2014, 64(6): 1275-1281. DOI: 10.1161/HYPERTENSIONAHA.114.03863.
[13] GIUSEPPINA A, CLAUDIA K. A novel “complement-metabolism-inflammasome axis” as a key regulator of immune cell effector function[J]. Eur J Immunol, 2016, 46(7): 1563-1573. DOI: 10.1002/eji.201546131.
[14] TRIANTAFILOU M, HUGHES T R, MORGAN B P, et al. Complementing the inflammasome[J]. Immunology, 2016, 147(2): 152-164. DOI: 10.1111/imm.12556.
[15] HESS C, KEMPER C. Complement-mediated regulation of metabolism and basic cellular processes[J]. Immunity, 2016, 45(2): 240-254. DOI: 10.1016/j.immuni.2016.08.003.
[16] KOLEV M, DIMELOE S, LE FRIEC G, et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses[J]. Immunity, 2015, 42(6): 1033-1047. DOI: 10.1016/j.immuni.2015.05.024.
[17] LI K, ANDERSON K J, PENG Q, et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation[J]. Blood, 2008, 112(13): 5084-5094. DOI: 10.1182/blood-2008-05-156646.
[18] CROKER D E, HALAI R, KAESLIN G, et al. C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment[J]. Immunol Cell Biol, 2014, 92(7): 631-639. DOI: 10.1038/icb.2014.32.
[19] KASTL S P, SPEIDL W S, KAUN C, et al. The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation[J]. J Thromb Haemost, 2006, 4(8): 1790-1797. DOI: 10.1111/j.1538-7836.2006.02046.x.
[20] HASHIMOTO M, HIROTA K, YOSHITOMI H, et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis[J]. J Exp Med, 2010, 207(6): 1135-1143. DOI: 10.1084/jem.20092301.
[21] GRAILER J J, BOSMANN M, WARD P A. Regulatory effects of C5a on IL-17A, IL-17F, and IL-23[J]. Front Immunol, 2013, 3: 387. DOI: 10.3389/fimmu.2012.00387.
[22] HERNANDEZ A L, KITZ A, WU C, et al. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells[J]. J Clin Invest, 2015, 125(11): 4212-4222. DOI: 10.1172/JCI81151.
[23] KASAL D A, BARHOUMI T, LI M W, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury[J]. Hypertension, 2012, 59(2): 324-330. DOI: 10.1161/HYPERTENSIONAHA.111.181123.
[24] MIAN M O R, BARHOUMI T, BRIET M, et al. Deficiency of T-regulatory cells exaggerates angiotensin Ⅱ-induced microvascular injury by enhancing immune responses[J]. J Hypertens, 2016, 34(1): 97-108. DOI: 10.1097/HJH.0000000000000761.
[25] WENZEL U, TURNER J E, KREBS C, et al. Immune mechanisms in arterial hypertension[J]. J Am Soc Nephrol, 2016, 27(3): 677-686. DOI: 10.1681/asn.2015050562.
[26] KHAN M A, SHAMMA T. Complement factor and T-cell interactions during alloimmune inflammation in transplantation[J]. J Leukoc Biol, 2019, 105(4): 681-694. DOI: 10.1002/JLB.5RU0718-288R.
[27] VAN DER TOUW W, CRAVEDI P, KWAN W H, et al. Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells[J]. J Immunol, 2013, 190(12): 5921-5925. DOI: 10.4049/jimmunol.1300847.
[28] CHEN X H, RUAN C C, GE Q, et al. Deficiency of complement C3a and C5a receptors prevents angiotensin Ⅱ-induced hypertension via regulatory T cells[J]. Circ Res, 2018, 122(7): 970-983. DOI: 10.1161/CIRCRESAHA.117.312153.
[29] WU J, THABET S R, KIRABO A, et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase[J]. Circ Res, 2014, 114(4): 616-625. DOI: 10.1161/CIRCRESAHA.114.302157.
[30] LIU Y M, RAFFERTY T M, RHEE S W, et al. CD8⁺ T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension[J]. Nat Commun, 2017, 8: 14037. DOI: 10.1038/ncomms14037.
[31] WENZEL U O, BODE M, KURTS C, et al. Salt, inflammation, IL-17 and hypertension[J]. Br J Pharmacol, 2019, 176(12): 1853-1863. DOI: 10.1111/bph.14359.
[32] KIRABO A, FONTANA V, DE FARIA A P C, et al. DC isoketal-modified proteins activate T cells and promote hypertension[J]. J Clin Invest, 2014, 124(10): 4642-4656. DOI: 10.1172/jci74084.
[33] WANG H X, LI W J, HOU C L, et al. CD1d-dependent natural killer T cells attenuate angiotensin Ⅱ-induced cardiac remodelling via IL-10 signalling in mice[J]. Cardiovasc Res, 2019, 115(1): 83-93. DOI: 10.1093/cvr/cvy164.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Recommended Articles

Metrics

Comments

[1]	HUANG Shengnan,ZHAO Rui,XIAO Nuan. Developments on telemedicine in management of senile hypertension [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(4): 39-44.
[2]	WANG Jing, HAN Li, ZHANG Zeming. Advances on chronic obstructive pulmonary disease associated pulmonary hypertension [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 21-28.
[3]	WANG Xinxin, LI Lu, WU Guangyi. Advances on the role of purine receptor in blood pressure regulation [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(1): 1-7.
[4]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(3): 29-33.
[5]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(3): 7-11.
[6]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(2): 36-40.
[7]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(1): 32-36.
[8]	. [J]. Medical Reserch and Education, 2019, 36(6): 21-27.
[9]	LIU Bin, LIU Lixia, ZANG Aimin, MA Tao, WANG Ping, ZHANG Yonggang. Observation of influence of radiotherapy and chemotherapy on T Lymphocytes subsets in patients with nasopharyngeal carcinoma [J]. Medical Reserch and Education, 2015, 32(6): 25-29.
[10]	ZONG Keliang, TIAN Lei, LIU Wenyi, GAO Congli, GENG Limei, FANG Huiyong. Analysis on current status of hypertension and its related factors in government functionaries of a large state-owned enterprise [J]. Medical Reserch and Education, 2015, 32(5): 55-60.
[11]	LIU Bin, LIU Lixia, ZANG Aimin, MA Tao, WANG Ping, ZHANG Yonggang. Observation of influence of radiotherapy and chemotherapy on T Lymphocytes subsets in patients with nasopharyngeal carcinoma [J]. Medical Reserch and Education, 2015, 32(5): 42-45.
[12]	. Effects of nursing intervention on prognosis of patients with hypertensive intracerebral hemorrhage [J]. Medical Reserch and Education, 2013, 30(2): 67-70.
[13]	. Association between gene polymorphism of angiotensin-1 receptor and essential hypertension [J]. Medical Reserch and Education, 2012, 29(6): 13-16.